Mauro Magnani is an expert in Biochemistry at University of Urbino (Italy). Mauro Magnani has authored 696 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 2,095 (community average: 125). How the SLR is computed.

LeadR Profile

Mauro Magnani University of Urbino Italy
2 095 ScienceLeadR Reputation 2095
Network Map

Biochemistry

Subspecialties: Immunology - Infectiology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1978 - 2026

Source: PubMed

University of Urbino Dept. Biomolecular Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 696

Citations

Citations: 18 538 1st author: 110 Last author: 273 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Proteomics in Ataxia Telangiectasia Fibroblasts Revealed Disease Hallmarks Recovered by ATM Variants.
PMID 42794514 — cells, genes, telangiectasis, ataxia telangiectasia, proteomics, ataxia, fibroblasts, extracellular matrix
Int J Mol Sci20260
Red Blood Cell-Encapsulated Nanoparticles for Long-Circulating, Improved Specificity Functional MRI.
PMID 42358790 — cells, erythrocytes, blood, nanoparticles, blood cells
Chem Biomed Imaging20262
Predicting the success of an antibody: Biochemical and biophysical characterization of the humanized monoclonal antibody Dia-T51.
PMID 42097429 — stress, physiological, antibodies, monoclonal, therapeutics
Int J Biol Macromol20260
Synthesis and Characterization of a Novel Biphenol-Based Gadolinium Complex for Encapsulation in Human Red Blood Cells.
PMID 42074136 — cells, contrast media, erythrocytes, blood, blood cells, retention, psychology, tissues
Int J Mol Sci20260
Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.
PMID 42039169 — cells, hiv-1, immunization, vaccines, follow-up studies, acquired immunodeficiency syndrome, vaccination, hiv, cell count, genes, tat, immune reconstitution, therapeutics, infections
Front Immunol20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 3 3
Phase 2 2
Phase 1 1

By status:

Completed 8
Recruiting 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 1
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map